274 related articles for article (PubMed ID: 21885483)
1. Serum hepcidin: a direct link between anemia of inflammation and coronary artery atherosclerosis in patients with rheumatoid arthritis.
Abdel-Khalek MA; El-Barbary AM; Essa SA; Ghobashi AS
J Rheumatol; 2011 Oct; 38(10):2153-9. PubMed ID: 21885483
[TBL] [Abstract][Full Text] [Related]
2. Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia.
van Santen S; van Dongen-Lases EC; de Vegt F; Laarakkers CM; van Riel PL; van Ede AE; Swinkels DW
Arthritis Rheum; 2011 Dec; 63(12):3672-80. PubMed ID: 22127690
[TBL] [Abstract][Full Text] [Related]
3. Soluble transferrin receptor, ferritin and soluble transferrin receptor--Ferritin index in assessment of anaemia in rhaeumatoid arthritis.
Pavai S; Jayaranee S; Sargunan S
Med J Malaysia; 2007 Oct; 62(4):303-7. PubMed ID: 18551934
[TBL] [Abstract][Full Text] [Related]
4. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index.
Skikne BS; Punnonen K; Caldron PH; Bennett MT; Rehu M; Gasior GH; Chamberlin JS; Sullivan LA; Bray KR; Southwick PC
Am J Hematol; 2011 Nov; 86(11):923-7. PubMed ID: 21812017
[TBL] [Abstract][Full Text] [Related]
5. Hepcidin, an acute-phase protein and a marker of inflammation in kidney transplant recipients with and without coronary artery disease.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2006 Nov; 38(9):2895-8. PubMed ID: 17112858
[TBL] [Abstract][Full Text] [Related]
6. Serum pro-hepcidin could reflect disease activity in patients with rheumatoid arthritis.
Kim HR; Kim KW; Yoon SY; Kim SH; Lee SH
J Korean Med Sci; 2010 Mar; 25(3):348-52. PubMed ID: 20191031
[TBL] [Abstract][Full Text] [Related]
7. A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients.
Malyszko J; Malyszko JS; Mysliwiec M
Transplant Proc; 2009 Oct; 41(8):3056-9. PubMed ID: 19857675
[TBL] [Abstract][Full Text] [Related]
8. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S
Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
[TBL] [Abstract][Full Text] [Related]
9. Hepcidin and iron deficiency in pre-kidney transplant patients.
Sancho A; Pastor MC; Troya M; Bonal J; Bayés B; Morales-Indiano C; Lauzurica R; Romero R
Transplant Proc; 2009; 41(6):2079-81. PubMed ID: 19715836
[TBL] [Abstract][Full Text] [Related]
10. Anemia in heart and kidney allograft recipients: is there a role for hepcidin?
Przybylowski P; Malyszko J; Malyszko JS; Koc-Zorawska E; Sadowski J; Mysliwiec M
Transplant Proc; 2010 Dec; 42(10):4255-8. PubMed ID: 21168677
[TBL] [Abstract][Full Text] [Related]
11. Hepcidin is not a marker of chronic inflammation in atherosclerosis.
Oğuz A; Uzunlulu M; Hekim N
Anadolu Kardiyol Derg; 2006 Sep; 6(3):239-42. PubMed ID: 16943108
[TBL] [Abstract][Full Text] [Related]
12. Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality.
Nikolaisen C; Figenschau Y; Nossent JC
J Rheumatol; 2008 Mar; 35(3):380-6. PubMed ID: 18260177
[TBL] [Abstract][Full Text] [Related]
13. Serum hepcidin-25 may replace the ferritin index in the Thomas plot in assessing iron status in anemic patients.
Thomas C; Kobold U; Balan S; Roeddiger R; Thomas L
Int J Lab Hematol; 2011 Apr; 33(2):187-93. PubMed ID: 20868446
[TBL] [Abstract][Full Text] [Related]
14. Single values of serum transferrin receptor and transferrin receptor ferritin index can be used to detect true and functional iron deficiency in rheumatoid arthritis patients with anemia.
Suominen P; Möttönen T; Rajamäki A; Irjala K
Arthritis Rheum; 2000 May; 43(5):1016-20. PubMed ID: 10817554
[TBL] [Abstract][Full Text] [Related]
15. Iron metabolism, hepcidin, and anemia in orthotopic heart transplantation recipients treated with mammalian target of rapamycin.
Przybylowski P; Malyszko JS; Macdougall IC; Malyszko J
Transplant Proc; 2013; 45(1):387-90. PubMed ID: 23375326
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 receptor antagonist gene polymorphism and hepcidin in rheumatoid arthritis: Correlations with clinical and laboratory indices of disease activity.
Swellam M; Gabal KM; Youssef SS
IUBMB Life; 2013 Oct; 65(10):883-8. PubMed ID: 24014495
[TBL] [Abstract][Full Text] [Related]
17. Is hepcidin a link between anemia, inflammation and liver function in hemodialyzed patients?
Małyszko J; Małyszko JS; Hryszko T; Pawlak K; Mysliwiec M
Am J Nephrol; 2005; 25(6):586-90. PubMed ID: 16254410
[TBL] [Abstract][Full Text] [Related]
18. Low serum levels of prohepcidin, but not hepcidin-25, are related to anemia in familial amyloidosis TTR V30M.
Beirão I; Almeida S; Swinkels D; Costa PM; Moreira L; Fonseca I; Freitas C; Cabrita A; Porto G
Blood Cells Mol Dis; 2008; 41(2):175-8. PubMed ID: 18544472
[TBL] [Abstract][Full Text] [Related]
19. Serum prohepcidin concentrations in rheumatoid arthritis.
Jayaranee S; Sthaneshwar P; Sokkalingam S
Pathology; 2009 Feb; 41(2):178-82. PubMed ID: 18972320
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]